CCT6A, a novel prognostic biomarker for Ewing sarcoma

BACKGROUND: Ewing sarcoma (ES), the second most prevalent bone malignant tumor has no widely known prognostic biomarker. Earlier studies have suggested that chaperonin containing TCP1 complex 6A (CCT6A), which encodes a molecular protein chaperone, is involved in the pathogenesis of many cancers. Ho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Jiang, Jie, Liu, Chong, Xu, Guoyong, Liang, Tuo, Yu, Chaojie, Liao, Shian, Zhang, Zide, Lu, Zhaojun, Wang, Zequn, Chen, Jiarui, Chen, Tianyou, Li, Hao, Zhan, Xinli
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
5700
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850773/
https://ncbi.nlm.nih.gov/pubmed/33530265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000024484
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars